Researchers sought to determine the relationship among hospitalization for COPD exacerbation, AF burden, and risk for subsequent stroke.

SGLT2 inhibitors, compared with GLP1 agonists, significantly lower risk for atrial fibrillation in patients with type 2 diabetes.

Abbott has reported new data from its prospective, non-randomised Volt CE Mark Study, indicating that individuals treated ...

Emerging pulsed field ablation systems had their moments in the spotlight at the annual meeting of the Heart Rhythm Society ...

One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal AfibDual-energy ...

Pulmonary embolism (PE) is a significant cause of morbidity and mortality, particularly in patients classified as acute, ...

‘Training on synthetic fibrosis images achieved a 0.943 ROC-AUC—nearly matching real MRI data (0.952). AI is transforming heart treatment.#aiinhealthcare #medindia ’ Existing methods like ...

James Robson suffers from atrial fibrillation but will compete for Cambridge University at this year's Boat Races Three years ago, James Robson was rowing with a Great Britain team-mate when he ...

Atrial dysfunction is a risk factor for atrial arrhythmia and can be detected by atrial strain imaging in patients with biventricular circulation. However, the role of atrial strain imaging for risk ...

We're talking about current issues in atrial fibrillation management. Professor Wellens, I've followed your work with great admiration over the years. Can you tell me how you see the field of ...

In patients with AF, abelacimab, compared with rivaroxaban, is associated with decreased bleeding across multiple bleeding risk categories. Abelacimab is associated with reduced bleeding compared ...